Connor, Clark & Lunn Investment Management (CC&L)
KYNB

Connor, Clark & Lunn Investment Management (CC&L)’s Kyntra Bio KYNB Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,163
Closed -$25.9K – 1512
2024
Q2 		$25.9K Buy
+1,163
New +$35.9K ﹤0.01% 1341
2023
Q4 		– Sell
-4,378
Closed -$94.4K – 1433
2023
Q3 		$94.4K Buy
+4,378
New +$172K ﹤0.01% 1295
2023
Q2 		– Sell
-1,070
Closed -$499K – 1371
2023
Q1 		$499K Buy
+1,070
New +$566K ﹤0.01% 882
2022
Q3 		– Sell
-471
Closed -$124K – 1153
2022
Q2 		$124K Sell
471
-1,368
-74% -$350K ﹤0.01% 970
2022
Q1 		$553K Sell
1,839
-814
-31% -$284K ﹤0.01% 768
2021
Q4 		$935K Buy
2,653
+1,534
+137% +$478K ﹤0.01% 690
2021
Q3 		$286K Buy
1,119
+442
+65% +$157K ﹤0.01% 884
2021
Q2 		$451K Sell
677
-687
-50% -$396K ﹤0.01% 805
2021
Q1 		$1.18M Buy
1,364
+148
+12% +$158K 0.01% 666
2020
Q4 		$1.13M Buy
+1,216
New +$1.28M 0.01% 612
2019
Q4 		– Sell
-466
Closed -$431K – 980
2019
Q3 		$431K Buy
+466
New +$512K ﹤0.01% 715
2016
Q1 		– Sell
-1,208
Closed -$920K – 855
2015
Q4 		$920K Sell
1,208
-176
-13% -$117K 0.01% 455
2015
Q3 		$758K Buy
+1,384
New +$838K 0.01% 450

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GC
GFG Capital Miami, Florida $363M AUM 45.53% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s KYNB Position: Q3 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Kyntra Bio (KYNB) in Q3 2024, closing a stake of 1,163 shares — an estimated $25.9K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in KYNB in Q3 2015 and held it in 13 quarters. The position peaked at $1.18M in Q1 2021. 70 funds tracked by Wall St. Rank hold KYNB as of Q3 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Kyntra Bio position as of Q3 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 1,163 Kyntra Bio shares in Q3 2024, an estimated $25.9K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Kyntra Bio in Q3 2015 and held it in 13 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Kyntra Bio position peaked at $1.18M in Q1 2021.
  • 70 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2024, filed 8 Nov 2024.